Staphylococcus aureus is a successful human pathogen that has developed several approaches to evade the immune system, including resistance strategies to prevent oxidative killing by immune cells. One mechanism by which this evasion occurs is by production of superoxide dismutase enzymes, which require manganese as a cofactor. Manganese is acquired by the manganese transporter MntABC. One component of this operon, MntC, has been proposed as a potential vaccine candidate due to its early in vivo expression and its ability to provide protection in preclinical models of staphylococcal infection. In the current study, we interrogate the role of this protein in protecting S. aureus from oxidative stress. We demonstrate that mutation of mntC in a number of invasive S. aureus clinical isolates results in increased sensitivity to oxidative stress. In addition, we show that while downregulation of mntC transcription is triggered upon exposure to physiological concentrations of manganese, MntC protein is still present on the bacterial surface at these same concentrations. Taken together, these results provide insight into the role of this antigen for the pathogen.
Introduction
Staphylococcus aureus is the causative agent of diseases ranging from benign skin infections to life-threatening endocarditis, osteomyelitis, toxinoses, and bacteremia. Proliferation and virulence of this pathogen is dependent on its ability to scavenge essential metals which are normally sequestered by the host [1] . Historically, emphasis has been placed on the role of iron in S. aureus virulence (for recent reviews see [2] [3] [4] [5] ). However, recent reports suggest that manganese is also necessary for S. aureus virulence [6] [7] [8] . Resistance to oxidative stress by S. aureus can be attributed to the activity of superoxide dismutase enzymes, which use manganese as a cofactor and inactivate reactive oxygen species [9] [10] [11] . Corbin et al. demonstrated that calprotectin, a neutrophilassociated protein which chelates Mn 2+ , limits growth of S. aureus both in vitro and in abscesses [6] . Manganese chelation by calprotectin lowers S. aureus superoxide dismutase activity and renders the bacteria more sensitive to oxidative stress and killing by neutrophils [12] .
ATP-binding cassette (ABC) transporters have been shown to play a central role in manganese transport in several species of bacteria [13] [14] [15] . However, the mechanism of manganese uptake by S. aureus is incompletely defined. S. aureus encodes an ABC transporter, MntABC, where mntA encodes the ATP-binding protein, mntB encodes the integral membrane protein, and mntC encodes the cation-binding lipoprotein. While S. aureus also encodes an additional manganese transporter, the Nramp homolog mntH, it appears that S. aureus imports manganese primarily by its ABC transporter [7] . Horsburgh et al showed that mutation of mntA in a laboratory isolate, 8325-4, resulted in a reduced growth rate and greater sensitivity to oxidative stress in vitro (although this strain background encodes a truncated copy of mntH [16] ). In addition, it was shown that transcription of mntABC is down regulated by its cognate repressor, MntR, which, upon binding to Mn 2+ , blocks transcription of the mntABC operon. Deletion of mntA also resulted in slightly lowered virulence in a murine abscess model, but only when mntH was also insertionally inactivated [7] .
MntC is a component of a tetravalent S. aureus vaccine currently under investigation in human clinical trials (U. S. National Institutes of Health Clinical Trial registry numbers NCT01364571 and NCT01643941) which, in addition to MntC, includes antigens designed to address immune evasion (capsular polysaccharide) and adhesion to host tissues (clumping factor A) [17] . It has recently been shown that MntC is a highly conserved protein among staphylococci; MntC homologs from 11 Staphylococcus species were found to share an average pairwise identity of 72% [18] . In addition, MntC was found to be surface expressed rapidly following infection of mice with a diverse group of S. aureus isolates [18] . Active vaccination with purified recombinant MntC significantly reduced both S. aureus and S. epidermidis bacterial burden in a mouse bacteremia model, suggesting that it may be an effective vaccine antigen for the prevention of S. aureus infection [18] .
Here we present a brief report describing the precise regulation of mntABC expression by MntR and corresponding MntC protein levels. We also demonstrate that MntC is surface expressed at physiological concentrations of manganese and that it plays a key role in providing resistance to oxidative stress across diverse disease-causing clinical isolates.
Materials and Methods
Primers, strains, plasmids, and growth media Primers, strains, and plasmids used in the current study are listed in Table 1 . To make TSB-c medium, TSB (BD, Franklin Lakes, NJ) was stirred in the presence of 1% (w/v) Chelex 100 beads (Sigma-Aldrich, St. Louis, MO) for 4 hours. The medium was then filter-sterilized and supplemented with MgCl 2 and Fe (II) SO 4 to final concentrations of 50 mM and 1 mM, respectively. Inductively-coupled mass spectrometry analysis (performed by Robertson Microlit Laboratories, Ledgewood, NJ) of four independently prepared batches of the TSB medium that had been treated with Chelex 100 beads revealed that the medium contained 50 nM manganese 617 nM.
Construction of a mntC knockout strain
A mntC::neo knockout cassette consisting of two 800 bp fragments (mntC-1 and mntC-2) flanking the neomycin resistance gene, neo, was constructed. The primer sets and DNA templates used to amplify each of the fragments were: (i) mntC-1: oLH81/oLH82, S. aureus COL genomic DNA; (ii) neo: oLH83/oLH84, pUB110; (iii) mntC-2: oLH85/oLH86, S. aureus COL genomic DNA. All PCRs were performed with iProof polymerase (Bio-Rad, Hercules, CA), and all cloning and molecular biology techniques were performed as described [19] . After purification, these three PCR products were spliced together by amplification with oLH81 and oLH86, and the knockout cassette was cloned into pSPT181 at the BamHI site. After electroporation and chromosomal integration into S. aureus RN4220, the final mntC::neo mutant strain was obtained after plasmid excision by secondary recombination. The mutation was introduced into other S. aureus isolates by transduction using protocols described previously [20] . In the resulting neomycin resistant transductants, insertional inactivation of mntC was confirmed by PCR. Mutants were shown to be of the expected strain lineage with a Qualicon RiboPrinter (DuPont, Wilmington, DE).
Construction of a mntR knockout strain
A mntR::ermC knockout cassette, consisting of two ,1.2 kb fragments (mntR-1 and mntR-2) flanking the erythromycin resistance gene, ermC, was constructed. The primer sets and DNA templates used to amplify each of the fragments were: (i) mntR-1: oLH202/oLH203, S. aureus COL genomic DNA; (ii) ermC: oLH204/oLH205, pE194; (iii) mntR-2: oLH206/oLH207, S. aureus COL genomic DNA. After purification, these three products were spliced together by amplification with oLH202 and oLH207, and the knockout cassette was cloned into pSPT181 at the BamHI and SalI sites. After electroporation and chromosomal integration into S. aureus RN4220, the final mntR::ermC mutant strain was obtained after plasmid excision by secondary recombination. This mutation was transduced into S. aureus 8325-4 geh::pLH76 essentially as described elsewhere [20] . In the resulting erythromycin resistant transductants, insertional inactivation of mntR was confirmed by PCR. Mutants were shown to be of the expected strain lineage with a Qualicon RiboPrinter.
Construction of TT-P mntABC -Rluc and TT-Rluc reporter fusions and reporter assays
To more easily monitor the levels of mntABC promoter activity, a transcriptional fusion was constructed comprised of the Renilla luciferase (Rluc) gene placed under the control of the mntABC promoter (P mntABC ). To prevent non-specific read-through transcription, a transcriptional terminator (TT) from pI258 (as described in [21] ) was amplified with primers oLH431 and oLH432. The P mntABC promoter fragment, which included the MntR binding box sequences [7, 22] , was amplified from S. aureus Newman genomic DNA with primers oLH398 and oLH433. The promoterless Rluc reporter gene was amplified from pRL-null (Promega, Madison, WI) with primers oLH434 and oLH435. Each of these products was purified (QIAquick PCR Purification Kit, Qiagen, Valencia, CA) and were spliced together by amplification with primers oLH431 and oLH435 to give TT-P mntABC -Rluc. A promoterless version of this cassette, TT-Rluc, was constructed with PCR primers oLH431 and oLH442 for TT and oLH443 and oLH435 for Rluc. These two PCR products were purified and spliced together as before to yield TT-Rluc. The TTRluc and TT-P mntABC -Rluc cassettes were cloned into the L54a attPencoding integrative vector, pLH71 (see Table 1 for more detail), at EcoRI and BamHI sites yielding pLH75 and pLH76, respectively. These plasmids were transformed into S. aureus RN4220/ pLH69 by electroporation, where pLH69 encodes the phage L54a integrase [23] [24] [25] [26] . After integration of the plasmids into the chromosome at geh was confirmed, pLH69 was cured from the strain, and the cassettes were transduced into S. aureus strains 8325-4 and 8325-4 mntR::ermC essentially as described elsewhere [20] .
S. aureus strains with chromosomally integrated reporters bearing either a promoterless Rluc (8325-4 geh::pLH75) or P mntABC -Rluc (8325-4 geh::pLH76) were cultured at 37uC in TSBc medium to mid-exponential phase of growth, then subcultured into the same medium containing increasing concentrations of supplemental MnSO 4 to a final optical density at 600 nm (OD 600 ) of 0.01. After one hour incubation with shaking at 37uC, 40 mL of each culture was mixed with 10 mL of 5X Renilla luciferase lysis buffer (Promega) in an opaque white 96-well plate, and the plate was shaken for two minutes at 200 rpm at room temperature. Fifty mL of Renilla luciferase substrate (Promega) was added and the samples were shaken for an additional two minutes before measuring relative luminescence on a Spectramax M5e (Molecular Devices, Sunnyvale, CA).
Western blot hybridization for MntC
Cells were grown overnight in TSB-c at 37uC with shaking, and subcultured (1:200 dilution) the following day in fresh TSB-c supplemented with the indicated concentration of MnSO 4 . Cells were harvested in the mid-exponential phase of growth, lysed with lysostaphin, and proteins were denatured in SDS-PAGE loading buffer. Following electrophoretic fractionation and transfer, Western blots were probed with murine anti-MntC 78-7 monoclonal antibody (at 3 mg/mL) as the primary antibody, and goat anti-mouse IgG (H+L)-AP Conjugate (Bio-Rad; diluted 1:5,000) as the secondary antibody. Western blots were processed using standard protocols [27] .
Assessment of MntC surface expression by whole cell ELISA
Selected clinical isolates from each clonal complex and their cognate mntC::neo mutant derivatives were grown in 5 mL TSB-c overnight at 37uC with shaking. The next day, cultures were diluted 1:200 into TSB-c containing 400 nM MnSO 4 . Cultures were shaken at 37uC until they reached an OD 600 = 0.6 -0.9. An OD 600 equivalent of 5 was collected, pelleted by centrifugation, and the supernatant was decanted. Cells were resuspended in 1 mL of 1X DPBS (Invitrogen, Carlsbad, CA) +20% glycerol and frozen at 270uC until use. Frozen cells were diluted 1:10 in 1X DPBS, and 100 mL of each strain of S. aureus was added per well to Table 1 . Primers, strains, and plasmids used in the study. . One hundred mL of 4 mg/mL IgG-purified polyclonal antibodies from either naïve or anti-MntC rabbit sera [18] diluted 1:800 in 20% porcine serum in sterile 1X DPBS was added to each well and incubated at 4uC for 2 hours. Plates were washed three times as described above, then 100 mL of goat anti-rabbit-AP secondary antibody (Southern Biotech, Birmingham, AL) diluted 1:1000 in 20% porcine serum was added to each well and plates were incubated at room temperature for 1 hr. Plates were then washed three times as described above, followed by the addition of 100 mL Alkaline Phosphatase Reagent for ELISA (Sigma-Aldrich).
Plates were incubated for 15 min at room temperature and optical densities at 405 nm were determined. The experiment was performed four times, and each of these experiments was done with an independently grown panel of S. aureus cells.
Assessment of MICs to methyl viologen
The Minimal Inhibitory Concentration (MIC) of methyl viologen (Sigma-Aldrich) necessary to inhibit bacterial growth was determined by broth microdilution according to standard protocols [28] with either TSB-c or TSB-c supplemented with 10 mM MnSO 4 as the growth medium. MIC determinations were made during at least two independent assays.
Results and Discussion
mntABC transcription and MntC expression are observed at physiological levels of Mn
2+
The US Department of Health reports that the normal range for manganese levels in humans is ,4 to 15 mg/L in blood, which is equivalent to 73 nM to 273 nM [29] . It has been reported that manganese-mediated repression of mntABC transcription occurs via MntR [7] . However, the manganese concentrations tested were higher than levels normally encountered in human blood ($1 mM) and therefore higher than what S. aureus would normally encounter during bacteremia. We therefore sought to more clearly define the concentrations of Mn 2+ that regulate mntABC at the level of transcript and protein expression. A transcriptional fusion of the mntABC promoter with Rluc was constructed to facilitate precise definition of the manganese concentration required for the regulation of mntABC transcription.
S. aureus strains with chromosomally integrated reporters bearing either a promoterless Rluc (S. aureus 8325-4 geh::pLH75) or P mntABC -Rluc (8325-4 geh::pLH76) were cultured in TSB-c medium containing various concentrations of supplemental MnSO 4 . The promoterless Rluc strain had minimal levels of reporter activity at all concentrations of MnSO 4 tested ( Figure 1A ). In contrast, S. aureus 8325-4/ P mntABC -Rluc, which contained Rluc under the control of a 67 bp mntABC promoter fragment, exhibited high levels of reporter activity in the absence of supplemental MnSO 4 . Consistent with previously published results [7] , reporter activity decreased as a function of increasing MnSO 4 in the culture.
The observed repression of reporter activity in the presence of manganese is likely due to the metalloregulatory protein, MntR, responding to increasing Mn 2+ as described previously [7] . To confirm this hypothesis, a mntR knockout mutant was constructed. As shown in Figure 1A , deletion of mntR relieved the manganesedependent repression of the P mntABC -Rluc reporter. These results indicate that expression and regulation of this promoter-reporter system work in a similar fashion to what has been published previously [7] . Unlike the earlier study that utilized a mntA-lacZ fusion containing a 578 bp promoter fragment, these results illustrate that a 67 bp P mntABC fragment is sufficient to support both expression of mntABC and Mn 2+ -dependent regulation by MntR. To determine the minimum concentration of manganese at which expression of mntABC was repressed by MntR, S. aureus 8325-4/ P mntABC -Rluc was cultured in the presence of two-fold serial dilutions of Mn 2+ ( Figure 1B ). At concentrations of 78 nM MnSO 4 and below, levels of reporter activity were high (between 1.5610 5 and 2610 5 relative light units, RLU). Higher concentrations triggered repression of reporter activity, and maximal repression was observed at concentrations of $156 nM MnSO 4 . Despite this repression, reporter activity was still observed, indicating that, under these growth conditions, MntR only down regulates expression without abolishing it. These results indicate that S. aureus responds to extracellular concentrations of manganese in the range found in human blood (73 nM to 273 nM). The observation that mntABC transcription is not completely repressed at these concentrations correlates well with in vivo expression of MntC [18] . The Mn 2+ concentration at which promoter repression occurs also correlates with the experimentally determined binding affinity of purified MntC for Mn 2+ , which is in the nanomolar range [30] .
To determine the degree to which manganese-dependent repression of mntABC RNA expression impacts MntC protein production, S. aureus 8325-4 wild-type, 8325-4 mntC, and 8325-4 mntR strains were cultured in TSB-c supplemented with increasing concentrations of Mn 2+ . As shown in Figure 2 , expression of MntC protein was highest in the absence of manganese. In addition, there was a clear down-regulation of MntC protein levels in the S. aureus 8325-4 wild-type strain as a function of increasing levels of Mn 2+ in the culture medium. As expected, no MntC protein was detectable in S. aureus 8325-4 mntC at any concentration of Mn 2+ tested. For S. aureus 8325-4 mntR, levels of MntC protein were high and not affected by the concentration of manganese in the growth medium. These results indicate that, although manganesemediated repression of mntABC transcription by MntR lowers the concentration of MntC protein, it is still expressed at the manganese concentrations which were tested under these growth conditions.
MntC is present on the surface of diverse S. aureus clinical isolates
Although mntC has been shown to be highly conserved across S. aureus isolates, its role in bacterial fitness, virulence and resistance to neutrophil killing in clinically relevant disease-causing isolates has yet to be demonstrated. In order to show that, (1) the results described above with the laboratory strain 8325-4 could be extended to clinically relevant strains, and (2) the levels of MntC detected by Western Blot correlate with surface expression, we performed whole cell ELISAs using anti-MntC polyclonal antibodies on representative clinical isolates grown in vitro. The isolates were selected from the five S. aureus clonal complexes most often associated with global disease: CC5, CC8, CC22, CC30, and CC45 [31] . As shown in Figure 3 , we found that MntC was detected on the surface of each of the clinical isolates tested and that the level of expression for three of the five strains was equivalent to that observed in the 8325-4 laboratory strain.
Inactivation of mntC results in sensitivity to oxidative stress across S. aureus clinical isolates
Polymorphonuclear neutrophils are important cellular mediators of the immune response to S. aureus. These immune cells are adept at killing engulfed bacteria through the production of a respiratory burst, i.e., a potent cocktail of superoxide radicals, hydrogen peroxide, and hydroxyl radicals that is secreted into the phagosome [32] . Methyl viologen (or paraquat), a quaternary ammonium compound which generates intracellular superoxide [33, 34] , is frequently used in vitro to mimic the oxidative stress that the bacteria encounter during the respiratory burst. Increased sensitivity to methyl viologen was observed with a S. aureus mntA mutant made in the laboratory strain background, 8325-4 [7] . This mutation in the first gene in the operon (mntA) likely resulted in polar effects that disrupt expression of the downstream genes mntB and mntC. In addition, it has been shown that S. aureus 8325-4 encodes a truncated copy of the Nramp homolog mntH [16] , so it cannot be concluded that the mutation in mntA was the sole cause of the observed sensitivity to methyl viologen (i.e., the observed phenotype may require mutation of both manganese transport systems). As a result, experiments were performed to look specifically at the contribution of the MntC vaccine antigen to S. aureus sensitivity to oxidative stress. Further, given that the previous observation was made with only a single laboratory strain of S. aureus, it was important to determine whether mntC-inactivation was similarly important for resistance to oxidative stress in diverse S. aureus strains that cause human disease. To test this possibility, a mntC mutation was transduced from S. aureus RN4220 into twelve clinical isolates from nosocomial infections representing different clonal complexes, including the five most often associated with invasive disease. Among the 12 isogenic pairs of clinical isolates were two MRSA strains, including one USA300, a lineage associated mainly with community-acquired infections. In order to quantitate the effect of mntC inactivation, minimum inhibitory concentrations (MICs) of methyl viologen were determined for wild-type and mntC isogenic strains in Mn 2+ -depleted media (Table 2) . Without exception, all mntC strains were more sensitive to methyl viologen than their wild-type counterparts. Relative to the respective wild type strains, the methyl viologen MICs were at least 8-fold lower in the mntC mutants. When mntC was supplied in trans, this effect was reversed and resistance to methyl viologen was restored to wild-type levels (data not shown). Further, resistance to methyl viologen was restored when the mntC mutant strains were cultured in the presence of manganese (Table 2 ). These data demonstrate that increased sensitivity to oxidative stress is a general characteristic when mntC is disrupted in S. aureus. We conclude that the MntC plays a central role in resistance to oxidative stress across invasive S. aureus clinical isolates.
MntC regulation and its role in resistance to oxidative stress
In the current study, we sought to further define the regulation of MntC and its role in resistance to oxidative stress in S. aureus. Using a chromosomally-integrated mntABC promoter-reporter fusion, we demonstrated that transcription of mntABC is repressed in the presence of Mn 2+ in a MntR-dependent manner. Further, we showed that down-regulation of the promoter-reporter fusion occurred at physiologically relevant concentrations of manganese [29] . Under these growth conditions, expression from the mntABC promoter was down regulated at Mn 2+ concentrations greater than 156 nM. However, complete repression was never observed, even at micromolar concentrations of manganese. In contrast, Horsburgh et al, reported complete repression of mntABC at very high concentrations of manganese by Northern blot analysis ($10 mM) [7] . This discrepancy could be explained either by the relative sensitivity of the Rluc reporter construct as compared to a Northern blot, or by the potential contribution of additional negative regulators whose binding sites were not present in the 67 bp promoter fragment used in our construct. We also found that MntC was surface expressed at 400 nM MnSO 4 in S. aureus clinical isolates representative of the most prevalent diseasecausing strains. Finally, mntC mutation correlated with heightened sensitivity to oxidative stress in a wide spectrum of clinical isolates.
Several antigens have been proposed as potential vaccine components for the prevention of staphylococcal infections [35] . Because manganese plays an important role in S. aureus virulence, antibodies resulting from vaccination with MntC have the potential to prevent MntC-mediated uptake of Mn 2+ by S. aureus, thereby rendering the organism more sensitive to oxidative killing by host immune cells. The results presented above, in combination with the high degree of protein sequence conservation and the demonstration of surface expression during murine models of infection [18] and human infection [36] make MntC an interesting candidate for assessment as a S. aureus vaccine antigen.
